CNS pipeline · person
Peter Miles Davies
Non-Executive Director of Neuphoria Therapeutics (formerly Bionomics) since July 2021 and a member of the Audit and Risk Management Committee. He worked in the healthcare team at Apeiron Investment Group and previously spent 2006 to 2021 at Rothschild & Co. He received his Master's degree from the University of Edinburgh, Scotland.
- 1 company
Courtesy Neuphoria Therapeutics
Current roles
- Neuphoria Therapeutics, Inc.Non-Executive Director · Board2021–present
Appears with
People sharing a company with Peter.
- Alan Fisher · Neuphoria Therapeutics, Inc.
- David Wilson · Neuphoria Therapeutics, Inc.
- Jane Ryan · Neuphoria Therapeutics, Inc.
- Liz Doolin · Neuphoria Therapeutics, Inc.
- Spyridon "Spyros" Papapetropoulos · Neuphoria Therapeutics, Inc.
- Tim Cunningham · Neuphoria Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.